A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients with Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
Details
Age
Adult
Type of Study
Treatment
Locations
UCHealth Central Park Medical Center
University of Colorado Hospital
Principal Investigator
Stacy Dixon, MD, PhD
Study ID
Protocol Number: 21-3397
More information available at ClinicalTrials.gov: NCT04886518
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers